4-hydroxy-2-nonenal protects against cardiac ischemia-reperfusion injury via the Nrf2-dependent pathway
miR-16 and miR-223 are also identified as targets to distinguish patients with early RA from healthy individuals ( Most of the aberrant miRNA levels can alter the secretion of inflammatory cytokines or MMPs, further affecting the procession of RA
Bai Y, Kim J-Y, Watters JM, Fang B, Kinose F, Song L, et al
Neuroscience 62 , 553567 (1994)
[,,] Current focused clinical and preclinical research concentrates on glutamate-modulating agents in OCD patients since, currently available treatments for OCD involve drugs that impact the serotonin and dopamine systems, although they are not very helpful in healthcare settings